ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Type 3 innate lymphoid cells as an indicator of renal dysfunction and serum uric acid in hyperuricemia

Chen, Zan-Xiong; Liu, Hong-Qian; Wu, Zhen-Hua; He, Jun-Lian; Zhong, Hao-Jie*广东药学院; 1
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE2023-3DOI: 10.17219/acem/154625
4被引8阅读
引用收藏
分享

摘要

Background. Type 3 innate lymphoid cells (ILC3s) are a newly identified group of innate immune cells that participate in the progression of several metabolic diseases by secreting interleukin (IL)-17 and IL-22. These cytokines are associated with hyperuricemia (HUA) severity and development; however, the relationship between ILC3s and HUA remains unclear. @@@ Objectives. To determine the characteristics of circulating ILC3s in patients with HUA. @@@ Materials and methods. Type 3 innate lymphoid cells and their subsets were detected using flow cytometry in peripheral blood mononuclear cells (PBMCs) of 80 HUA patients and 30 healthy controls (HC). Plasma levels of IL-17A and IL-22 were measured with enzyme-linked immunosorbent assay (ELISA). Clinical data of enrolled subjects were collected from electronic medical records. @@@ Results. In patients with HUA, the frequency of circulating ILC3s was elevated and positively correlated with levels of serum uric acid and serum creatinine (Scr). Although there was no significant difference in the plasma concentration of IL-17A between the patients with HUA and healthy controls, positive correlations between plasma IL-17A and the concentration of serum uric acid and frequency of circulating ILC3s were observed in the patients with HUA. @@@ Conclusions. In patients with HUA, positive correlations were detected between circulating ILC3 levels, plasma IL-17A and serum uric acid. Therefore, ILC3s and IL-17A may be useful indicators of disease severity, and are potential new therapeutic targets in HUA.

学科与关键词

关键词
uric acidinnate immunityinterleukin-17creatininehyperuricemia
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE
发表日期
2023-03
卷期
第 32 卷, 第 3 期
页码
307-313
DOI
10.17219/acem/154625
成果收录
SCIE
资助标注
China Postdoctoral Science Foundation [2021M700034]; High-level Hospital Construction Research Project of Maoming People's Hospital, China

作者

  • C

    Chen, Zan-Xiong (第一作者)

  • L

    Liu, Hong-Qian

    1 · guangdong pharmaceut univ

查看全部 5 位作者收起作者
  • W

    Wu, Zhen-Hua

  • H

    He, Jun-Lian

    1 · guangdong pharmaceut univ

  • Z

    Zhong, Hao-Jie (通讯)

    1 · guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417